Pharma: Das zweifelhafte Milliardengeschäft mit Frauen in den Wechseljahren
Aus dem Handelsblatt-Archiv: Investoren und Pharmafirmen stecken Milliarden in Produkte für Frauen in der Menopause. Dennoch fehlt es an wirksamen Therapien. Ein deutscher Anbieter profitiert.
Munich. For decades, investors and pharmaceutical companies showed little interest in the complaints of women going through menopause – even though more than half of the global population experiences this stage in their lives. Suddenly, hot flashes have become a hot business. Financial investors and private funders are pouring billions into the sale of products for women in menopause.
Telemedicine providers promote hormone therapy. Companies are offering programs for women in menopause as a new "employee benefit." The era of women silently enduring their symptoms and keeping the topic of menopause out of public view is over. Influencers and celebrities like Oprah Winfrey and Serena Williams are promoting menopause products, with the hashtag #menopause garnering billions of views on TikTok.
The long overdue momentum is here. However, the effectiveness of the investment boom in addressing the real problem remains to be seen.
Written by urgent.news from Handelsblatt's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
- Pharma: The dubious billion-dollar business with women in menopause handelsblatt.com
